Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in chronic hemodialysis patients
Author(s) -
M. Hayashi,
Shinji Kaneko,
M. Shimano,
Tomohiro Ohashi,
Ryuji Kubota,
Kyosuke Takeshita,
Masanori Shinoda,
Yasuya Inden,
Hitoshi Kanayama,
Toyoaki Murohara
Publication year - 2013
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gft233
Subject(s) - medicine , atrial fibrillation , hemodialysis , catheter ablation , cardiology , radiofrequency ablation , catheter , ablation , intensive care medicine , surgery
Radiofrequency catheter ablation (RFCA) is increasingly performed for the treatment of atrial fibrillation (AF), but it is problematic because the use of anti-arrhythmic agents is largely restricted in patients undergoing hemodialysis (HD) therapy. However, little is known about the long-term clinical outcomes of AF after RFCA in HD patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom